Design and Evaluation of Fast Dissolving Tablets of Anti-Hypertensive Poorly Soluble Drug through 23 Factorial Designs
Chandra SND1*, Bharathi A2, Suresh SBAV3, Shabana P1
1Professor, Nimra College of Pharmacy, Ibrahimpatnam, Vijayawada, Andhra Pradesh, India.
2Professor, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India.
3Professor, School of Pharmacy, G.H. Raisoni Universiy, Saikheda, Madhya Pradesh, India
Received: 8th Feb, 2024; Revised: 27th Sep, 2024; Accepted: 7th Oct, 2024; Available Online: 25th Dec, 2024
ABSTRACT
The purpose of this study was to improve the anti-hypertensive effect of telmisartan fast-dissolving tablets by formulating them with a synthetic superdisintegrant. The effects of three factors—SH [A], SSG [B], and CCS [C] on dependent variables like the in vitro method, water absorption, and percent drug release at 10 minutes were investigated in this survey using three factors in a two-level (23) factorial design. The production of starch hyaluronate, a fine, freely- flowing crystalline powder, was accomplished by the esterification process. The ester bond between starch and hyaluronic acid was confirmed by FTIR analysis, and starch hyaluronate did not interact with the medication in the DSC testing. The formulation with the shortest disintegration time, TF2, took only 24±0.2 seconds to complete. In ten minutes,
93.68 ±1.32% of the medicines from the optimal composition had dissolved. Moreover, a mixture containing a 5% level of starch hyaluronate was refined and could be utilized in creating quickly dissolving tablets. This formula also improved clinical compliance during the effective treatment of hypertension. The optimized composition was able to achieve a low concentration of a novel synthetic super disintegrate in a short amount of time.
Key words: factorial design, Telmisartan, pH, Superdisintegrant, Antihypertensive
How to cite this article: SND Chandra, Bharathi A, Suresh SBAV, Shabana P. Design and Evaluation of Fast Dissolving Tablets of Anti-Hypertensive Poorly Soluble Drug through 23 Factorial Designs. International Journal of Drug Delivery Technology. 2024;14(4):1988-95. doi: 10.25258/ijddt.14.4.7
REFERENCES
- Hiremath SP, Makanapur C. Formulation and evaluation of orodispersible tablets of a model anti- hypertensive drug. Int J Pharm Pharm Sci. 2017; 9 (10):34.
- Bhide P, Nachinolkar R. Formulation development and characterisation of meclizine hydrochloride fast dissolving tablets using solid dispersion technique. Int J App Pharm. 2018;10 (4):141.
- Jayapal N, Vamshi Vishnu Y. Formulation and in vivo evaluation of self-nanoemulsifying drug delivery system of ramipril in wistar rats. Asian J Pharm Clin Res. 2021; 14 (7):126-36.
- Chauhan K, Solanki R, Sharma S. A review on fast dissolving tablet. Int J App Pharm. 2018; 10(6):10(6):1.
- Radha GV, Sastri KT, Prathyusha P, Bhanu P, Rajkumar Formulation and evaluation of aceclofenac proniosome loaded orabase for management of dental pain. Int J App Pharm. 2018; 10(6):204.
- Patel SS, Patel NM. Development of directly compressible co-processed excipient for dispersible tablets using 32 full factorial design. Int J Pharm Pharm Sci. 2009; 1:125-48.
- Hossain MS, Hossain MA, Anisuzzman M. Formulation development and evaluation of carvedilol tablet. Int Res J Pharm. 2013; 4(8):96-100.
- Jire DS, Gosavi NS, Badhe RB, Jagdale DH. Mouth dissolving tablet: a novel drug delivery Asian J Pharm Res. 2021; 14:180-6.
- Prakash Rao AHO, Rada SK, Kandukuri S. Optimization of starch crotonate as a novel superdisintegrant in the formulation of fast dissolving tablets through 23 factorial design. Int J App Pharm. 2021; 7:247-56.
- Naik DCS, Bharathi A. 23 Full Factorial Designs for Formulation and Evaluation of Non-Steroidal Anti- inflammatory Drug. International Journal of Drug Delivery Technology. 2022; 12(1):1-7. DOI: 25258/ijddt.12.1.1